The 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID), Geneve, Switzerland, 24 - 29 May 2021, vol.1, no.95, pp.366
Background: Limited studies have been published on practices and management of corona virus disease 2019 in children from the beginning of the pandemic. With this study, we aimed to share the clinical and epidemiological characteristics of infection in pediatric patients and our experiences.
Methods: Corona virus disease-2019 reverse-transcription polymerase chain reaction test positive pediatric patients we followed up in our hospital between March to December 2020 were included in the study. The epidemiological, laboratory, radiological, and clinical data of the patients were analyzed retrospectively.
Results: 246 patients were admitted, the median age was 9 years, girls were %53. 76 (31%) patients were asymptomatic. Common symptoms; cough, fever, and sore throat. 199 (81%) have a family history, 32 (12%) patients had comorbidity. Laboratory findings; lymphopenia, eosinopenia, high C-reactive protein. Case classes; asymptomatic (32%), mild (52%), moderate (14%), severe (1.2%), critical (0.4%). 48 (19.5%) were inpatients and 11 (4.5%) were in intensive care. Tomography was performed 25 (10%) and 10 (4%) were abnormal. 22 (8%) patients received favipiravir,16 (%6) antibiotics, 4 (1.6%) steroid and 3 (1.2%) heparin.
Conclusions: Although corona virus disease 2019 is often asymptomatic and mild in children, it may
rarely have a severe course. More caution should be exercised in children under 1 year of age and in
patients with comorbidities.